Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of prednisone-induced hyperglycemia in adults with hematologic cancers
PACTR201807745027158Phase 2Recruiting
- Sponsor
- Lucy Ochola
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin in corticosteroid-induced hyperglycemia (GIH) (2 arms), sponsored by Lucy Ochola. Primary endpoint: Effectiveness of metformin in preventing prednisone-induced hyperglycemia. Started Jun 2018; status: recruiting.
02
Drugs
metformin
03
Conditions
corticosteroid-induced hyperglycemia (GIH)
Beyond the preview
Go deeper on PACTR201807745027158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201807745027158.